GSK-3 inhibition leads to TFEB dephosphorylation, which correlates with TFEB dislocation from 14-3-3 chaperones and TFEB nuclear localization in the pancreatic cancer cell [40]. This evidence concerns the gene TFEB and pancreatic neoplasm.